# ASCC1 review notes ## Deep research status Attempted `just deep-research-falcon human ASCC1 --fallback perplexity-lite` on 2026-06-03. Falcon timed out after the wrapper's 600-second provider timeout, and the configured `perplexity-lite` fallback failed with a Perplexity API 401 quota error. No `ASCC1-deep-research-falcon.md` or fallback provider report was created. This review therefore uses the cached primary literature, UniProt/GOA, Reactome entries, and the PN projection report directly. ## Summary ASCC1 encodes the p50 subunit of the human ASC-1/ASCC complex. The strongest evidence supports two connected nuclear roles: - transcription coactivation as part of ASC-1, with the endogenous complex required for AP-1, SRF, and NF-kappaB transactivation [PMID:12077347 "these results suggest that the endogenous hASC-1 complex appears to play an essential role in AP-1, SRF, and NF-kappaB transactivation"]. - accessory/regulatory participation in ALKBH3-ASCC DNA alkylation repair, where ASCC1 interacts through ASCC3 and coordinates proper ASCC recruitment during alkylation damage [PMID:29997253 "ASCC1 coordinates the proper recruitment of the ASCC complex during alkylation"]. Human loss-of-function genetics supports biological importance in neuromuscular development, but the immediate molecular interpretation remains ASC-1/ASCC complex dysfunction rather than an independent developmental signaling activity [PMID:26924529 "Our findings indicate that the dysfunction of a transcriptional coactivator complex can result in a clinical syndrome affecting the neuromuscular system."]. ## Proteostasis PN projection The PN projection report proposes two candidate additions for ASCC1: GO:0006515 protein quality control for misfolded or incompletely synthesized proteins and GO:0072344 rescue of stalled cytosolic ribosome, from `Translation|Cytosolic translation|Ribosome-associated QC|Ribosomal rescue` [file:projects/PROTEOSTASIS/reports/pn_projection/pn_projected_candidate_additions.tsv "ASCC1 GO:0072344 rescue of stalled cytosolic ribosome"]. I did not promote these to ASCC1 GO annotations. The ASCC1-specific literature reviewed here supports nuclear ASCC transcription and alkylation-damage repair, not cytosolic ribosome rescue. The key ASCC alkylation-damage paper says ASCC1 loss affects ASCC3/ASCC2 recruitment and MMS sensitivity [PMID:29997253 "ASCC1 knockout through a CRISPR/Cas9 approach results in alkylation damage sensitivity in a manner epistatic with ASCC3."]. The broader ASCC pathway paper ties ASCC foci to alkylated nucleotides, elongating RNA polymerase II, splicing factors, and K63-linked ubiquitin signaling rather than ribosome rescue [PMID:29144457 "These foci associate with alkylated nucleotides, and coincide spatially with elongating RNA polymerase II and splicing components."]. Conservative PN decision: treat the ASCC1 ribosomal-rescue/RQC projection as unsupported by ASCC1-specific evidence in this review. It remains a suggested expert question rather than a proposed annotation. ## Annotation decisions - Accepted nuclear and nuclear-speck localization. PMID:29997253 directly says ASCC1 is present at nuclear speckle foci before damage and leaves those foci after alkylation [PMID:29997253 "ASCC1 is present at nuclear speckle foci prior to damage, but leaves the foci in response to alkylation."]. - Accepted DNA alkylation repair and DNA repair complex participation. PMID 22055184 establishes ALKBH3 association with ASCC and a repair mechanism [PMID:22055184 "Our data provide a molecular mechanism by which ALKBH3 collaborates with ASCC to maintain genomic integrity in a cell-type specific manner."]. PMID:29144457 establishes an alkylation-specific ubiquitin pathway and ASCC1/ASCC3 complex association [PMID:29144457 "Mass spectrometric analysis of ASCC2-associated proteins revealed the constitutive association of ASCC3 and ASCC1"]. - Removed DNA replication. The cited ASCC1 paper supports alkylation damage repair, not DNA replication. The related ASCC pathway paper reports foci in G1/early S and distinct from PCNA, which is insufficient for direct DNA replication curation [PMID:29144457 "These foci were also distinct from GFP-PCNA or BMI-1"]. - Marked generic protein binding annotations as over-annotated. ASCC1 physical interactions are real, especially with ASCC3, but GO:0005515 is less useful than ASCC complex membership and DNA alkylation repair [PMID:29997253 "ASCC1 interacts with the ASCC complex through the ASCC3 helicase subunit."]. - Marked RNA binding as over-annotated rather than core. PMID:29997253 supports a putative RNA-binding motif requirement, but does not itself demonstrate direct ASCC1 RNA binding [PMID:29997253 "a function that appears to depend on a putative RNA-binding motif near the ASCC1 C terminus."]. PMID:29144457 shows direct ssRNA binding for ASCC3, not ASCC1 [PMID:29144457 "Purified ASCC3 bound to ssRNA in vitro"]. ## Falcon deep research findings (2026-06-07) A Falcon (Edison Scientific) deep research report was generated on 2026-06-07 (`ASCC1-deep-research-falcon.md`), superseding the earlier failed Falcon attempt noted above. Synthesis of KEY findings, emphasizing what is NEW relative to the existing COMPLETE review: - NEW (most material): Direct, sequence-selective RNA binding by ASCC1 is now experimentally demonstrated. Chinnam et al. 2024 (PMID:38750793, J Biol Chem) solved crystal/SAXS structures and showed by EMSA that ASCC1 binds CGCG-containing RNA (detectable at ~60 nM), abolished by a KH GXXG->GDDG mutation, with no shift on the corresponding DNA. This is the first DIRECT ASCC1 RNA-binding evidence and partially addresses the prior caveat that only ASCC3 (not ASCC1) had shown direct nucleic-acid binding. The existing GO:0003723 RNA binding annotation (currently MARK_AS_OVER_ANNOTATED) is now better supported as a genuine molecular activity, though physiological endogenous RNA targets remain undefined. Note PMID:38750793 is not in the local publications cache, so it is added as a statement-only reference and NOT used to flip the existing IEA annotation's action. - NEW (domain architecture): ASCC1 uniquely couples an N-terminal KH-like domain (with a newly named helix-clasp-helix / HCH nucleotide-binding motif) to a C-terminal two-histidine (2H) phosphodiesterase (PDE) / "RNA ligase-like" module with two HXT motifs [PMID:38750793]. This sharpens the prior generic "RNA-ligase-like region" description into a defined KH-HCH + 2H-PDE architecture. - PROVISIONAL/CAUTION (enzymology): The 2H-PDE domain is structurally present but NO catalytic activity was detected on a tested 2-5A substrate by human or Alvinella ASCC1 (positive control VP3-CTD cleaved >95%); an atypical conserved active-site histidine rotamer implies a noncanonical substrate [PMID:38750793]. Do NOT assert a specific PDE reaction/substrate. No GO catalytic-activity annotation is warranted at present. - CONFIRMS: ASCC1 is a regulatory/accessory subunit of the ASC-1/ASCC complex (with ASCC2, ASCC3, TRIP4); ASCC3 directly binds ASCC1 and scaffolds the ASCC1-ASCC2 association (ASCC1 and ASCC2 do not bind directly). ASCC1 localizes to nuclear speckles (co-localizing with PRP8) and leaves foci on alkylation damage; ASCC1 loss dysregulates ASCC2/ASCC3 recruitment and causes MMS hypersensitivity epistatic with ASCC3 (Soll 2018, PMID:29997253; Soll 2019 thesis). All already captured in the review. - NEW (pathway context, complex-level): The ASC-1/ASCC complex has expanding translation-linked roles. Kito et al. 2023 (PMID:37092320, EMBO J) found ASCC (ASCC1/2/3, TRIP4) associates with scanning ribosomes and promotes translation initiation on a subset of transcripts (ASCC3-driven). Miscicka et al. 2024 (PMID:38366554, Nucleic Acids Res) reconstituted ASCC-mediated ribosome disassembly downstream of ZNF598 ubiquitination and report ASCC1 is DISPENSABLE for the cytoplasmic ribosome-splitting step while remaining essential for the nuclear DNA-repair function. This is complex-level / ASCC3- and ASCC2-centric evidence and supports the existing conservative decision NOT to add cytosolic ribosome-rescue (RQC) GO annotations to ASCC1 specifically; it strengthens the suggested expert question on this point. - NEW (disease mechanism): Voraberger et al. 2023 (PMID:37455927, Front Endocrinol) gives a SMABF2 bone-mechanism: ASCC1 knockdown in hMSCs suppresses osteoblastogenesis (>90% reduced mineralization) and increases adipogenesis, with downregulation of RUNX2/SERPINF1 and reduced TGF-beta/SMAD3 signaling, framing ASCC1 as a pro-osteoblastogenic / anti-adipogenic regulator. This is downstream/pleiotropic disease-phenotype data; it elaborates the SMABF2 link (PMID:26924529) but does not by itself justify a new core molecular-function GO annotation. Captured as a reference and supporting context only. - PROVISIONAL (biomarker): Chinnam 2024 TCGA analysis (~7000 tumors) reports ASCC1 mRNA overexpression in 7/15 tumor types and a poor-prognosis association in pancreatic adenocarcinoma (HR ~3.7) [PMID:38750793]. Exploratory bioinformatic association only; not annotation-relevant. Net curation effect: add four genuinely-new primary references (PMID:38750793, PMID:37092320, PMID:38366554, PMID:37455927) as statement-only entries (full_text_unavailable), refine the GO:0003723 RNA binding review.reason to note the now-direct CGCG RNA-binding evidence (without changing the action), and add targeted suggested questions/experiments. No existing annotation action changed.